| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.07B | 122.39B | 115.36B | 109.55B | 106.69B | 104.26B |
| Gross Profit | 51.41B | 49.60B | 47.93B | 45.92B | 44.43B | 42.41B |
| EBITDA | 6.48B | 6.42B | 6.90B | 6.25B | 7.05B | 7.18B |
| Net Income | 1.17B | 1.26B | 1.86B | 1.61B | 2.39B | 2.20B |
Balance Sheet | ||||||
| Total Assets | 71.78B | 70.59B | 68.15B | 66.22B | 62.94B | 64.45B |
| Cash, Cash Equivalents and Short-Term Investments | 8.74B | 8.46B | 8.27B | 8.14B | 8.20B | 10.12B |
| Total Debt | 25.01B | 29.79B | 29.18B | 30.52B | 29.57B | 32.56B |
| Total Liabilities | 55.52B | 54.24B | 52.93B | 51.73B | 49.66B | 53.26B |
| Stockholders Equity | 16.16B | 16.26B | 15.17B | 14.45B | 13.27B | 11.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.75B | 5.62B | 3.37B | 1.88B | 3.68B |
| Operating Cash Flow | 0.00 | 4.46B | 7.72B | 4.97B | 4.01B | 5.21B |
| Investing Cash Flow | 0.00 | -3.73B | -3.65B | -2.11B | -2.51B | -1.49B |
| Financing Cash Flow | 0.00 | -544.00M | -3.94B | -2.92B | -3.42B | -5.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ¥19.36B | 6.76 | ― | 1.85% | 3.70% | 37.00% | |
| ― | ¥14.46B | 11.97 | ― | 2.40% | 5.93% | -36.11% | |
| ― | ¥11.21B | 15.39 | ― | 1.23% | 4.08% | 51.63% | |
| ― | ¥41.28B | 9.21 | ― | 1.34% | 7.12% | 14.14% | |
| ― | ¥6.16B | ― | ― | 2.61% | 15.66% | 56.93% | |
| ― | ¥19.49B | ― | ― | 3.70% | 15.00% | -195.87% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Medical System Network Co., Ltd. reported its consolidated financial results for the three months ended June 30, 2025, showing a 5.7% increase in net sales compared to the previous year. However, the company experienced a decline in operating and ordinary profits by 6.1% and 13.6%, respectively, with profit attributable to owners of the parent dropping by 54%. Despite these challenges, the company maintains its dividend forecast for the fiscal year ending March 31, 2026, indicating stability in shareholder returns.